The U.S. healthcare system is complex and evolving. For AbbVie to lead the industry in this environment, it is vital that our US Market Access (USMAx) Strategy and Pipeline Team thoroughly comprehend the current and future state of the evolving U.S. healthcare space and market access channels.
The Director, USMAx Pipeline, Oncology will lead U.S. market access strategy development for early oncology pipeline priority assets. The Director USMAx Pipeline Oncology will integrate the complex U.S. health system, particularly Medical Benefit dynamics, and the needs and requirements of U.S. payers into early asset development. This role will leverage clinical understanding, expertise of Evidence Based Medicine, alongside US health system knowledge, and competitive insights to shape pivotal clinical development programs for pre-launch compounds, bringing the voice of U.S. payers to our early drug development process.
Specific Responsibilities:
- Create an overall price, reimbursement and access (PRA) strategy for oncology portfolio aligned with the commercial strategy and overall AbbVie Oncology Strategy.
- Lead TouchPoint process working closely with in-line and field teams to ensure clinical programs are designed for success.
- Address reimbursement and pricing potential and inform early access assumptions across oncology portfolio.
- Strategically partner with PCS and IMAP to develop Early Integrated Value Proposition (EIVP) for key assets.
- Influence clinical development programs to ensure appropriate endpoints are incorporated that will optimize price, reimbursement and ultimately patient access in the US and globally and prepare our assets for future policy changes.
- Represent USMAx Early Pipeline at governance as needed (e.g., TASC, START, LMG, REO, etc).
- Support BD assessments by leading US access and price assumptions and coordinating effort with strategic pricing and in-line oncology teams as needed.
- Ensure project resource needs are met; secure and allocate budget across asset assignments to meet critical enterprise goals for Pipeline assets.
- Co-Lead the Value and Access Teams (VATs) with International Market Access (IMAP) Colleagues and lead creation of US EIVPs (Early Integrated Value Proposition) and Integrated Access Strategies (IAS).
- Lead the creation of Integrated Asset Strategies, Disease Area Strategies and Early Integrated Value Propositions within the AbbVie Oncology Portfolio and collaborate with Teams across BUs, IMAP, Medical, HEOR, IRA, R&D and others to ensure the value drivers of USMAx Decision Makers are incorporated into Pipeline Commercialization Strategies.
- Work closely across USMAx Teams, IRA and BESD teams to stay close to channel customer dynamics and priorities and ensure optimal asset planning and decision making.
Leadership Competencies:
The candidate will have a proven track record of supporting a positive team culture, building deep cross-functional stakeholder alignment, experience in U.S. payer marketing strategy development, and an understanding of the AbbVie Pipeline Commercialization Model.
The ideal candidate
- Builds strong relationships with peers and cross functionally with partners outside of team to enable higher performance
- Communicates complicated oncology topics in simplified stories for senior management, driving change
- Learns fast, grasps the 'essence' and can change the course quickly where indicated
- Raises the bar and is never satisfied with the status quo
- Creates a learning environment, open to suggestions and experimentation for improvement
- Embraces the ideas of others, nurtures innovation and manages innovation to reality